28/03/2026
🔬 Scientific Community Insight | Rational Prescribing in the Elderly
The growing burden of polypharmacy and inappropriate prescribing in elderly patients is a silent but significant threat to patient safety.
đź§ Key Messages
1. Aging alters drug response → reduced clearance, increased sensitivity, higher risk of adverse effects
2. Polypharmacy is highly prevalent → majority of elderly patients are on ≥5 drugs
3. Inappropriate prescribing is common → overuse, misuse, and duplication of therapies coexist
4. High-risk drugs frequently used → PPIs, benzodiazepines, NSAIDs, anticholinergics
5. Under-treatment also exists → evidence-based therapies are often missed
6. Drug–drug and drug–disease interactions are under-recognized
⚠️ Clinical Reality
This is not just a prescribing issue—
it reflects fragmented care, protocol-driven medicine, and lack of therapeutic individualization.
👨‍⚕️ Role of Clinical Pharmacologist — The Need of the Hour
1. Experts in rational pharmacotherapy and deprescribing
2. Essential for medication review, risk–benefit assessment, and optimization
3. Bridge the gap between guidelines and real-world patient complexity
🌿 Take-Home Message
Better outcomes in elderly care will not come from more drugs—
but from better, safer, and more rational use of drugs.
👉 Clinical Pharmacology must be integrated into routine patient care.
Well done Dr Rupak Chatterjee for leading this excellent work.
Link to read: https://journals.lww.com/jiag/fulltext/2026/01000/potentially_inappropriate_prescribing_in_the.10.aspx